Phase 3 Safety Comparisons for 1.0% Azithromycin in Polymeric Mucoadhesive Eye Drops versus 0.3% Tobramycin Eye Drops for Bacterial Conjunctivitis - Protzko, Eugene; Bowman, Lyle; Abelson, Mark; Shapiro, Aron; AzaSite Clinical Study Group (Investigative ophthalmology & visual science, 2007)
Keywords: Adhesives; Adolescent; Adult; Aged; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - adverse effects; Azithromycin - administration & dosage; Azithromycin - adverse effects; Biological and medical sciences; Child; Child, Preschool; Conjunctivitis, Bacterial - drug therapy; Eye and associated structures. Visual pathways and centers. Vision; Female; Fundamental and applied biological sciences. Psychology; Humans; Infant; Male; Middle Aged; Ophthalmic Solutions - administration & dosage; Ophthalmic Solutions - adverse effects; Polymers; Prospective Studies; Tobramycin - administration & dosage; Tobramycin - adverse effects; Treatment Outcome; Vertebrates: nervous system and sense organs; Visual Acuity; Phase; Control release polymer; Toxicity; Mucosa; Conjunctiva disease; Conjunctivitis; Infection; Eye drop; Eye disease; Antibiotic; Aminoglycoside; Bacteriosis; Bacteria; Protein synthesis inhibitor; Ophthalmology; Safety; Tobramycin; Antibacterial agent; Bioadhesive system; Comparative study